-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Market Perform on 10x Genomics, Raises Price Target to $90

Benzinga·09/29/2026 16:30:04
Diffusion vocale
Leerink Partners analyst Mike Kratky maintains 10x Genomics (NASDAQ:TXG) with a Market Perform and raises the price target from $40 to $90.